China Tracker - Details for China Kanghui Holdings (KH)

 China Kanghui Holdings
 Basic Facts and History
Data Source: Annual Report for the period ended 2009-12-31
Reporting Type: Foreign Company (20-F Filings) 
Incorporation: Cayman Islands 
Corporate Headquarters: China (Jiangsu) 
Going Public: IPO on 2010-08-11 
IPO Price: $10.25 (-100.00% since IPO)
IPO Lead Underwriter: Morgan Stanley 
Main Operating Subsidiary: Changzhou Kanghui Medical Innovation Co., founded 1997 
Investor Relations: Investor Relations Website 
Internal Controls: not effective 
Internal Controls Audit: not performed 
Auditor Opinion:

We were not engaged to perform an audit of the Company’s internal control over financial reporting. (Ernst & Young Hua Ming )

 
 Ownership
Main Shareholder: IDG-Accel China Growth Fund (Institutional) 
Ownership: 16.20% 
 
 Auditor Trail (since January 1, 2009)
2009-01-01Ernst & Young Hua MingAppointment
 
 Senior Management Trail (since January 1, 2009)
2010-01-01Junwen WangCFOAppointment
 
 Fiscal Year
Fiscal Year ends: December 31 
Annual Report 20-F: due by June 30 
KH
Healthcare & Drugs
SCORE
2
READ: Score Cards Explained
SAFETY/RISK SCORE
HIGH SAFETY
DETAILS: Safety/Risk Model for KH
Current Price:  n/a
F10k Day (2010-08-11): -100.00%$12.16
2010 Close: -100.00%$18.51
2011 Close: -100.00%$14.74
High (2012-10-15): -100.00%$30.74
Low (2012-05-25): -100.00%$18.72
Exchange:
Market Capitalization: n/a
Total Shares: 25.14 mill
Float: n/a
Avg Volume: 261.20 k
Short Interest: 1.33 mill
Short Ratio: 0.30%5.1 d
Last Quarter: 2011-03-31
Revenue (MRQ): 10.38 mill
Net Income (MRQ): 3.55 mill
all financial data provided without warranty